04/08/2020
6:30 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2020
7:28 AM | Aeglea Bio Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2020
6:34 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2020
6:30 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:15 PM | Aeglea Bio Therapeutics (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:14 PM | Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:14 PM | Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:13 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:12 PM | Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
11:00 AM | Aeglea Bio Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A
| |
02/13/2020
3:17 PM | Aeglea Bio Therapeutics (Subject)
Lilly Ventures Fund I LLC (Filed by)
| Form SC 13G/A
| |
02/12/2020
3:12 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aeglea Bio Therapeutics (Subject)
| Form SC 13G/A
| |
02/06/2020
1:01 PM | Aeglea Bio Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A
| |
02/03/2020
1:43 PM | Aeglea Bio Therapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A
| |
01/30/2020
3:12 PM | Aeglea Bio Therapeutics (Subject)
Novartis Bioventures Ltd (Filed by)
| Form SC 13G/A
| |
01/13/2020
4:20 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K/A
| |
01/13/2020
6:01 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2019
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
7:34 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
7:30 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2019
4:21 PM | Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
4:20 PM | Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2019
3:09 PM | Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2019
3:08 PM | Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/07/2019
3:09 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2019
6:30 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2019
5:03 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
7:03 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
4:22 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:52 PM | Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:51 PM | Aeglea Bio Therapeutics (Issuer)
Shanafelt Armen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:50 PM | Aeglea Bio Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:49 PM | Aeglea Bio Therapeutics (Issuer)
Magovcevic Ivana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:49 PM | Aeglea Bio Therapeutics (Issuer)
Cox Russell J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:48 PM | Aeglea Bio Therapeutics (Issuer)
Bruhn Suzanne Louise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:05 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2019
3:55 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
4:04 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
6:51 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
6:45 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2019
4:05 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2019
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2019
5:05 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2019
3:41 PM | Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2019
3:41 PM | Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2019
3:30 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2019
4:16 PM | Aeglea Bio Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2019
3:05 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
5:08 AM | Aeglea Bio Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
02/13/2019
11:15 PM | Aeglea Bio Therapeutics (Filer)
| Form EFFECT
| |
02/13/2019
3:29 PM | Aeglea Bio Therapeutics (Subject)
BAKER BROS. ADVISORS LP (Filed by)
| Form SC 13G/A
| |
02/11/2019
4:18 PM | Aeglea Bio Therapeutics (Filer)
| Form S-3/A
| |
02/08/2019
3:15 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2019
8:40 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2019
8:37 PM | Aeglea Bio Therapeutics (Filer)
| Form 424B5
| |
02/05/2019
3:49 PM | Aeglea Bio Therapeutics (Filer)
| Form 424B5
| |
01/31/2019
3:37 PM | Aeglea Bio Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G/A
| |
01/31/2019
10:20 AM | Aeglea Bio Therapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SC 13G/A
| |
12/21/2018
3:01 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2018
4:05 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2018
3:05 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
4:40 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2018
7:04 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2018
5:59 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2018
9:26 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aeglea Bio Therapeutics (Subject)
| Form SC 13G
| |
10/10/2018
8:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2018
4:11 PM | Aeglea Bio Therapeutics (Issuer)
Schuchart Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2018
4:00 PM | Aeglea Bio Therapeutics (Filer)
| Form DEF 14A
| |
09/04/2018
6:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2018
3:24 PM | Aeglea Bio Therapeutics (Issuer)
Schuchart Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2018
3:40 PM | Aeglea Bio Therapeutics (Issuer)
GEORGIOU GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2018
7:06 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2018
3:30 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2018
4:26 PM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2018
3:27 PM | Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2018
3:26 PM | Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/16/2018
8:04 AM | Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2018
5:47 PM | Aeglea Bio Therapeutics (Issuer)
Shanafelt Armen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
5:45 PM | Aeglea Bio Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
5:44 PM | Aeglea Bio Therapeutics (Issuer)
GEORGIOU GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
5:43 PM | Aeglea Bio Therapeutics (Issuer)
Cox Russell J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
5:42 PM | Aeglea Bio Therapeutics (Issuer)
Bruhn Suzanne Louise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2018
5:20 AM | Aeglea Bio Therapeutics (Subject)
Novartis Bioventures Ltd (Filed by)
| Form SC 13G/A
| |
05/14/2018
3:01 PM | Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2018
3:28 PM | Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
3:01 PM | Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2018
7:06 AM | Aeglea Bio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2018
7:00 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
3:06 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
3:02 PM | Aeglea Bio Therapeutics (Filer)
| Form 424B5
| |
04/17/2018
3:07 PM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2018
3:03 PM | Aeglea Bio Therapeutics (Filer)
| Form 424B5
| |
04/16/2018
6:03 AM | Aeglea Bio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2018
6:00 AM | Aeglea Bio Therapeutics (Filer)
| Form DEF 14A
| |
